HEXIM1 down-regulates hypoxia-inducible factor-1α protein stability

Biochemical Journal

Volumn 456, Issue 2, 2013, Pages 195-204

  Yeh, I Ju ^a   Ogba, Ndiya ^a   Bensigner, Heather ^a   Welford, Scott M ^a   Montano, Monica M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Breast cancer; Hexamethylene bis acetamide inducible protein 1 (HEXIM1); Histone deacetylase (HDAC); Hypoxia inducible factor 1 (HIF 1 ); Prolyl hydroxylase (PHD)

Indexed keywords

HEXAMETHYLENE BIS ACETAMIDE INDUCIBLE PROTEIN 1; HISTONE DEACETYLASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGENASE; PROLYL HYDROXYLASE 3; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HYDROXYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TUMOR INVASION; UBIQUITINATION; UPREGULATION;

ACETYLATION; BREAST NEOPLASMS; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; MCF-7 CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RNA-BINDING PROTEINS;

EID: 84887432218     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130592     Document Type: Article

References (50)

1. Harris, A. L. (2002) Hypoxia: a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47
2. Semenza, G. L. (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8
3. Lundgren, K., Holm, C. and Landberg, G. (2007) Hypoxia and breast cancer: prognostic and therapeutic implications. Cell. Mol. Life Sci. 64, 3233-3247
4. Dachs, G. U. and Tozer, G. M. (2000) Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer 26, 1649-1660
5. Mohyeldin, A., Garzón-Muvdi, T. and Quĩnones-Hinojosa, A. (2010) Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7, 150-161
6. Saltz, L. B., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T. S., Rivera, F. et al. (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J. Clin. Oncol. 26, 2013-2019
7. Brahimi-Horn, M. C., Chiche, J. and Pouysségur, J. (2007) Hypoxia and cancer. J. Mol. Med. 85, 1301-1307
8. Grépin, R. and Pagès, G. (2010) Molecular mechanisms of resistance to tumour anti-angiogenic strategies. J. Oncol. 2010, 835680
9. Mazure, N. M., Brahimi-Horn, M. C., Berta, M. A., Benizri, E., Bilton, R. L., Dayan, F., Ginouves, A., Berra, E. and Pouyssegur, J. (2004) HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem. Pharmacol. 68, 971-980
10. Bruick, R. K. and McKnight, S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Vasc. Pharmacol. 294, 1337-1340
11. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54
12. Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732
13. Jeong, J. W., Bae, M. K., Ahn, M. Y., Kim, S. H., Sohn, T. K., Bae, M. H., Yoo, M. A., Song, E. J., Lee, K. J. and Kim, K. W. (2002) Regulation and destabilization of HIF-1 by ARD1-mediated acetylation. Cell 111, 709-720
14. Ketchart, W., Smith, K. M., Krupka, T., Wittmann, B. M., Hu, Y., Rayman, P. A., Doughman, Y. Q., Albert, J. M., Bai, X., Finke, J. H. et al. (2012) Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene 32, 3829-3839
15. Wittmann, B. M., Wang, N. and Montano, M. M. (2003) Identification of a novel inhibitor of cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Res. 63, 5151-5158
16. Ogba, N., Doughman, Y. Q., Chaplin, L. J., Hu, Y., Gargesha, M., Watanabe, M. and Montano, M. M. (2010) HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland. Oncogene 29, 3639-3649
17. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (2001) Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206
18. Du, W., Wright, B. M., Li, X., Finke, J., Rini, B. I., Zhou, M., He, H., Lal, P. and Welford, S. M. (2013) Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma. Oncogene 32, 1469-1474
19. Ogba, N., Chaplin, L., Doughman, Y. Q., Fujinaga, K. and Montano, M. M. (2008) HEXIM1 regulates E2/ERα-mediated expression of Cyclin D1 in mammary cells via modulation of P-TEFb. Cancer Res. 68, 7015-7024
20. Wittmann, B. M., Fujinaga, K., Deng, H., Ogba, N. and Montano, M. M. (2005) The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor α and transcriptional elongation factor cyclin T1. Oncogene 24, 5576-5588
21. Montano, M. M., Ekena, K., Delage-Mourroux, R., Chang, W., Martini, P. and Katzenellenbogen, B. S. (1999) An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc. Natl. Acad. Sci. U.S.A. 96, 6947-6952
22. Appelhoff, R. J., Tian, Y. M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J. and Gleadle, J. M. (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465
23. Stiehl, D. P., Wirthner, R., Koditz, J., Spielmann, P., Camenisch, G. and Wenger, R. H. (2006) Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482-23491
24. Shen, C., Nettleton, D., Jiang, M., Kim, S. K. and Powell-Coffman, J. A. (2005) Roles of the HIF-1 hypoxia-inducible factor during hypoxia response in Caenorhabditis elegans. J. Biol. Chem. 280, 20580-20588
25. Chan, D. A., Kawahara, T. L., Sutphin, P. D., Chang, H. Y., Chi, J. T. and Giaccia, A. J. (2009) Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 15, 527-538
26. Yoo, Y. G., Kong, G. and Lee, M. O. (2006) Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1. EMBO J. 25, 1231-1241
27. Bilton, R., Mazure, N., Trottier, E., Hattab, M., Dery, M. A., Richard, D. E., Pouyssegur, J. and Brahimi-Horn, M. C. (2005) Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1 and is not induced by hypoxia or HIF. J. Biol. Chem. 280, 31132-31140
28. Fisher, T. S., Etages, S. D., Hayes, L., Crimin, K. and Li, B. (2005) Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J. Biol. Chem. 280, 17749-17757
29. Cronin, P. A., Wang, J. H. and Redmond, H. P. (2010) Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer 10, 225
30. Marlow, R., Strickland, P., Lee, J. S., Wu, X., Pebenito, M., Binnewies, M., Le, E. K., Moran, A., Macias, H., Cardiff, R. D. et al. (2008) SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res. 68, 7819-7827
31. Schietke, R., Warnecke, C., Wacker, I., Schodel, J., Mole, D. R., Campean, V., Amann, K., Goppelt-Struebe, M., Behrens, J., Eckardt, K. U. and Wiesener, M. S. (2010) The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J. Biol. Chem. 285, 6658-6669
32. Wong, C. C., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C. M., Khoo, U. S., Ng, I. O. et al. (2011) Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc. Natl. Acad. Sci. U.S.A. 108, 16369-16374
33. Khurana, A., Liu, P., Mellone, P., Lorenzon, L., Vincenzi, B., Datta, K., Yang, B., Linhardt, R. J., Lingle, W., Chien, J. et al. (2011) HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res. 71, 2152-2161
34. Minamishima, Y. A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R. T. and Kaelin, Jr, W. G. (2008) Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111, 3236-3244
35. Marxsen, J. H., Stengel, P., Doege, K., Heikkinen, P., Jokilehto, T., Wagner, T., Jelkmann, W., Jaakkola, P. and Metzen, E. (2004) Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4- hydroxylases. Biochem. J. 381, 761-767
36. Peurala, E., Koivunen, P., Bloigu, R., Haapasaari, K. M. and Jukkola-Vuorinen, A. (2012) Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients. Breast Cancer Res. Treat. 133, 179-188
37. Yan, M., Rayoo, M., Takano, E. A. and Fox, S. B. (2009) BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br. J. Cancer 101, 1168-1174
38. Huang, K. T., Mikeska, T., Dobrovic, A. and Fox, S. B. (2010) DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas. Histopathology 57, 451-460
39. Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A. and Semenza, G. L. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732-744
40. Anderson, K., Nordquist, K. A., Gao, X., Hicks, K. C., Zhai, B., Gygi, S. P. and Patel, T. B. (2011) Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins. J. Biol. Chem. 286, 42027-42036
41. Yoo, Y. G., Na, T. Y., Seo, H. W., Seong, J. K., Park, C. K., Shin, Y. K. and Lee, M. O. (2008) Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 27, 3405-3413
42. Geng, H., Liu, Q., Xue, C., David, L. L., Beer, T. M., Thomas, G. V., Dai, M. S. and Qian, D. Z. (2012) HIF1α protein stability is increased by acetylation at lysine 709. J. Biol. Chem. 287, 35496-35505
43. Ellis, L., Hammers, H. and Pili, R. (2009) Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett. 280, 145-153
44. Kang, F. W., Que, L., Wu, M., Wang, Z. L. and Sun, J. (2012) Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. Oncol. Rep. 28, 193-199
45. Naldini, A., Filippi, I., Cini, E., Rodriquez, M., Carraro, F. and Taddei, M. (2012) Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells. Anticancer Agents Med. Chem. 12, 407-413
46. Bodily, J. M., Mehta, K. P. and Laimins, L. A. (2011) Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 71, 1187-1195
47. Kato, A., Endo, T., Abiko, S., Ariga, H. and Matsumoto, K. (2008) Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. Exp. Cell Res. 314, 2661-2673
48. Seagroves, T. N. (2009) The complexity of the HIF-1-dependent hypoxic response in breast cancer presents multiple avenues for therapeutic intervention. In Pharmaceutical Perspectives of Cancer Therapeutics (Lu, Y. and Mahato, R. I., eds), pp. 521-558, Springer, New York
49. Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., Vandenberg, S., Johnson, R. S., Werb, Z. and Bergers, G. (2008) HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13, 206-220
50. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P. and Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864